Controversial drug prescriptions double after Mel…
You’ve heard of pseudoscience — but what about movie star science?
New research suggests a bombshell declare from Mel Gibson on influencer Joe Rogan’s well-liked podcast might have helped fuel a dramatic surge in prescriptions for an unproven cancer treatment.
During the January 2025 episode, which racked up more than 60 million views in its first month, the actor-director claimed three mates with Stage 4 cancer have been cured after taking the off-label routine.
Actor-director Mel Gibson appeared on “The Joe Rogan Experience” on January 9, 2025. YouTube / PowerfulJRE
The controversial medicine at the middle of the frenzy have been ivermectin — an antiparasitic that grew to become a flashpoint during the Covid-19 pandemic — and fenbendazole, a veterinary dewormer that isn’t FDA accredited for people. Gibson claimed all three of his mates no longer had the disease “at all” after taking the medicines.
In the months after his remarks, prescriptions for the mix jumped, with the steepest will increase among younger males, white sufferers and those in the South. Among cancer sufferers, prescription charges have been more than 2.5 instances greater, while in the South they surged to more than 3 times their 2024 ranges.
But consultants warning there may be little medical evidence to help the medicine for this use.
In laboratory cell and animal research, ivermectin and fenbendazole have shown some anti-cancer exercise — but the doses required for even a modest impact would sometimes be thought-about poisonous in people, according to Dr. Skyler B. Johnson of the University of Utah Huntsman Cancer Institute.
Johnson, who was not concerned in the research, told CIDRAP News he’s also involved ivermectin might intrude with how the physique processes cancer remedies and other medicines.
To date, no human medical trials have shown that ivermectin and fenbendazole are secure or efficient for treating cancer.
The research’s authors sounded the alarm that following unproven advice might value them their lives.
“As a primary care doctor, I want my patients and people across the country to have the chance to get treatments we know can help them live longer, healthier lives,” Dr. John N. Mafi, senior writer of the UCLA-led research, said in a press release.
Following Gibson’s endorsement, prescriptions for the controversial drug ivermectin skyrocketed nationwide. Jeffrey Daly – stock.adobe.com
“When prescribing for an unproven cancer treatment more than doubles after a single podcast, especially among men and people in the South, it raises a concern that patients may be skipping or delaying treatments we know work in favor of something that hasn’t been proven to help them,” he warned.
Co-author Dr. Katherine Kahn, a professor of medication at UCLA, burdened that “not all widely shared health information is accurate, even when it comes from familiar or influential sources.”
“Using unproven treatments can carry real risks, especially if it delays care that is known to work,” she said.
The researchers burdened that the research doesn’t show the podcast instantly brought on the spike in prescriptions.
It also stays unclear whether or not sufferers have been taking the medicine alongside customary cancer remedies — or instead of therapies such as chemotherapy or radiation.
The will increase have been largest among males, White sufferers, those in the US south and people with cancer. JAMA Network
But the findings add to growing issues among medical doctors over ivermectin’s off-label use.
The drug grew to become a lightning rod during the Covid-19 pandemic after being promoted on social media by influencers, politicians and even some physicians as a treatment and safety measure.
Now ivermectin is once again back in the headlines, with some online claims suggesting it might help deal with hantavirus following a lethal outbreak aboard a luxurious cruise ship.
Experts say there may be still no high-quality evidence in people exhibiting ivermectin works against either Covid-19 or hantavirus.
And while the National Cancer Institute announced earlier this 12 months that it’s learning ivermectin’s attainable anti-cancer properties, the research stays in the preclinical stage — which means any findings are still far from being prepared for precise sufferers.
The UCLA-led research raises major questions that researchers say ought to be explored in the future, including whether or not sufferers are changing confirmed cancer therapies with the drug combo, whether or not the remedies are inflicting hurt and which medical doctors are prescribing them.
“We often focus on how to efficiently get evidence into practice,” said research lead writer Dr. Michelle Rockwell of Virginia Tech.
“But these findings remind us that some forces can influence care very quickly. The challenge for health systems is how to meet patients in that moment with information that is both timely and trustworthy.”
We present you with the trending topics. Get the best latest Entertainment news and content on our web site daily.
